Cited by CrossRef (7)

  1. Arndt Vogel, Ana Lleo. Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry?. Liver International 2023;43:6
    https://doi.org/10.1111/liv.15474
  2. Nora Alzahrani, Ayman Al Jurdi, Leonardo V. Riella. Immune checkpoint inhibitors in kidney transplantation. 2023;28:46
    https://doi.org/10.1097/MOT.0000000000001036
  3. Matthew Man Pok Lee, Landon Long Chan, Stephen Lam Chan. The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma. JLC 2023;23:262
    https://doi.org/10.17998/jlc.2023.07.17
  4. Renea Jablonski. Lung Cancer and Lung Transplantation. Curr Pulmonol Rep 2023;12:1
    https://doi.org/10.1007/s13665-023-00301-4
  5. Ratna Acharya, Rachel Bush, Felicia Johns, Kiran Upadhyay. Efficacy and safety of local candida immunotherapy in recalcitrant warts in pediatric kidney transplantation: A case report. World J Transplant 2023;13:201
    https://doi.org/10.5500/wjt.v13.i4.201
  6. Ziyao Lu, Muhammad Afzal, Keisuke Shirai. Durable complete response to early immunotherapy discontinuation in a kidney transplant recipient with advanced cutaneous squamous cell carcinoma: A case report and review of literature. Transplant Immunology 2023;81:101932
    https://doi.org/10.1016/j.trim.2023.101932
  7. Dan L. Longo, Ashley Wysong. Squamous-Cell Carcinoma of the Skin. N Engl J Med 2023;388:2262
    https://doi.org/10.1056/NEJMra2206348